menu search

MEIP / MEI Pharma, Inc. (MEIP) Q4 2022 Earnings Call Transcript

MEI Pharma, Inc. (MEIP) Q4 2022 Earnings Call Transcript
MEI Pharma, Inc. (NASDAQ:MEIP ) Q4 2022 Results Conference Call September 8, 2022 5:00 PM ET Company Participants David Walsey - Senior Vice President and Corporate Affairs Dan Gold - President and Chief Executive Officer Brian Drazba - Chief Financial Officer David Urso - Chief Operating Officer and General Counsel Richard Ghalie - Chief Medical Officer Conference Call Participants Stephen Willey - Stifel Robyn Karnauskas - Truist Yale Jen - Laidlaw & Co Nick Abbott - Wells Fargo Operator Good afternoon, and welcome to the MEI Pharma 2022 Fiscal Year End Conference Call. Please be advised that the call is being recorded at the Company's request. Read More
Posted: Sep 8 2022, 21:00
Author Name: Seeking Alpha
Views: 110795

MEIP News  

All You Need to Know About MEI Pharma, Inc. (MEIP) Rating Upgrade to Strong Buy

By Zacks Investment Research
September 29, 2023

All You Need to Know About MEI Pharma, Inc. (MEIP) Rating Upgrade to Strong Buy

MEI Pharma, Inc. (MEIP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This mi more_horizontal

MEI Pharma, Inc. (MEIP) Q4 2023 Earnings Call Transcript

By Seeking Alpha
September 26, 2023

MEI Pharma, Inc. (MEIP) Q4 2023 Earnings Call Transcript

MEI Pharma, Inc. (NASDAQ:MEIP ) Q4 2023 Earnings Call Transcript September 26, 2023 5:00 PM ET Company Participants David Walsey - SVP, Corporate Affa more_horizontal

MEI Pharma, Inc. (MEIP) Reports Q3 Loss, Tops Revenue Estimates

By Zacks Investment Research
May 11, 2023

MEI Pharma, Inc. (MEIP) Reports Q3 Loss, Tops Revenue Estimates

MEI Pharma, Inc. (MEIP) came out with a quarterly loss of $2.32 per share versus the Zacks Consensus Estimate of a loss of $2.60. This compares to los more_horizontal

MEI Pharma, Inc. (MEIP) Reports Q1 Loss, Lags Revenue Estimates

By Zacks Investment Research
November 14, 2022

MEI Pharma, Inc. (MEIP) Reports Q1 Loss, Lags Revenue Estimates

MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 0% and 10.46%, respectively, for the quarter ended September 2022. Do the numbers more_horizontal

MEI Pharma, Inc. (MEIP) Q4 2022 Earnings Call Transcript

By Seeking Alpha
September 8, 2022

MEI Pharma, Inc. (MEIP) Q4 2022 Earnings Call Transcript

MEI Pharma, Inc. (NASDAQ:MEIP ) Q4 2022 Results Conference Call September 8, 2022 5:00 PM ET Company Participants David Walsey - Senior Vice President more_horizontal

MEI Pharma, Inc. (MEIP) Reports Q3 Loss, Tops Revenue Estimates

By Zacks Investment Research
May 23, 2022

MEI Pharma, Inc. (MEIP) Reports Q3 Loss, Tops Revenue Estimates

MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 0% and 55.10%, respectively, for the quarter ended March 2022. Do the numbers hold more_horizontal

Analysts Cut Price Target On MEI Pharma As Stock Falls To 52-Week Low After Zandelisib Update

By Benzinga
March 25, 2022

Analysts Cut Price Target On MEI Pharma As Stock Falls To 52-Week Low After Zandelisib Update

The FDA crushed MEI Pharma Inc's (NASDAQ: MEIP) hopes of winning accelerated approval for its PI3K inhibitor, zandelisib, on the strength of phase 2 more_horizontal

Why MEI Pharma Stock Is Plummeting After Hours

By Benzinga
March 24, 2022

Why MEI Pharma Stock Is Plummeting After Hours

MEI Pharma Inc (NASDAQ: MEIP) shares are plunging in Thursday's after-hours session after the company provided an investor update following a recent more_horizontal


Search within

Pages Search Results: